Ipca Laboratories has reported results for third quarter ended December 31, 2014.
The company has reported 70.15% fall in its net profit at Rs 41.53 crore for the quarter under review as compared to of Rs 139.12 crore for the same quarter in the previous year. Total income of the company has decreased 10.89% at Rs 747.09 crore for Q3FY15 as compared Rs 838.37 crore for the corresponding quarter previous year.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
